Minimally Invasive Surgery in Chronic Subdural Hematoma: Prognosis and Recurrence Factors of 516 Cases in a Single Center
Open Access
- 28 February 2022
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (5), 1321
- https://doi.org/10.3390/jcm11051321
Abstract
Objective: To investigate the effects of minimally invasive surgery (MIS) using a novel YL-1 puncture needle and summarize the risk factors of recurrence in chronic subdural hematoma (CSDH). Methods: We performed a retrospective analysis in 516 hospitalized patients with CSDH from January 2013 to December 2018 in Northern Jiangsu People’s Hospital. Patients’ gender, age, history of trauma, use of anticoagulants, history of disturbed liver or renal function, history of heart disease, history of malignant tumor, history of diabetes, hemodialysis, coagulopathy, alcoholism, imaging indicators, and postoperative application of urokinase or atorvastatin were recorded. Recurrence is defined by imaging examination with or without clinical presentation three months after discharge. Results: In total, 483 patients (93.60%) benefited from MIS by YL-1 needle. Gender, age, history of head trauma, history of disturbed liver function, history of heart disease, history of malignant tumor, history of diabetes, history of hemodialysis, coagulopathy, alcoholism, hematoma location, hematoma densities, septum formation, maximum thickness, encephalatrophy, and use of atorvastatin and urokinase were shown to be non-significantly associated with postoperative recurrence (p > 0.05). The use of anticoagulants was significantly associated with postoperative recurrence (p > 0. 05). Logistic analysis showed that the use of anticoagulants is an independent factor predicting postoperative recurrence (p > 0. 05). Conclusions: The novel YL-1 puncture needle turned out to be a safe and effective minimally invasive surgery, and the use of anticoagulants is an independent risk factor predicting postoperative recurrence in CSDH, which can provide MIS and early therapeutic strategies for neurosurgeons.This publication has 26 references indexed in Scilit:
- Effects of Atorvastatin on Conservative and Surgical Treatments of Chronic Subdural Hematoma in PatientsWorld Neurosurgery, 2016
- Minimally invasive approach in bilateral chronic subdural hematomas: surgical selection and outcome in 74 casesTurkish Neurosurgery, 2016
- Predictors of functional outcomes and recurrence of chronic subdural hematomasJournal of Clinical Neuroscience, 2015
- Epidural Hematoma Complication after Rapid Chronic Subdural Hematoma Evacuation: A Case ReportThe American Journal of Case Reports, 2015
- Vascular Endothelial Growth Factor Concentration in Chronic Subdural Hematoma Fluid Is Related to Computed Tomography Appearance and Exudation RateJournal of Neurotrauma, 2014
- Risk prognosis factors of chronic subdural hematoma evacuated by the novel YL-1 hollow needle aspiration drainage system.2014
- Effects of atorvastatin on chronic subdural hematoma: A preliminary report from three medical centersJournal of the Neurological Sciences, 2013
- Chemokines as markers of local inflammation and angiogenesis in patients with chronic subdural hematoma: a prospective studyActa Neurochirurgica, 2011
- A Randomized Controlled Trial Comparing the Outcome of Burr-Hole Irrigation with and without Drainage in the Treatment of Chronic Subdural Hematoma: A Preliminary ReportWorld Neurosurgery, 2011
- Use of twist-drill craniostomy with drain in evacuation of chronic subdural hematomas: independent predictors of recurrenceActa Neurochirurgica, 2010